Matthew Lastrapes

Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma

Nicholas D. Camarda, S. Carter, A. Iafrate, 2020, Nature Genetics.

The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in PIK3CA-Mutant Breast Cancer Brain Metastases

A. Giobbie-Hurder, S. Carter, H. Wakimoto, 2019, Clinical Cancer Research.

MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas.

A. Giobbie-Hurder, S. Carter, D. Cahill, 2019, Blood advances.

Microenvironmental correlates of immune checkpoint inhibitor response in human melanoma brain metastases revealed by T cell receptor and single-cell RNA sequencing

McKenzie L. Shaw, Brian L. Shaw, S. Carter, 2021, bioRxiv.

Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal Fluid

Brian L. Shaw, A. Giobbie-Hurder, S. Carter, 2021, JAMA network open.

DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome

Julie M. Batten, S. Carter, A. Iafrate, 2018, Acta Neuropathologica.

Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma

Nicholas D. Camarda, S. Carter, A. Iafrate, 2020, Nature Genetics.

Microenvironmental landscape of human melanoma brain metastases in response to immune checkpoint inhibition.

McKenzie L. Shaw, Brian L. Shaw, S. Carter, 2022, Cancer immunology research.